Compare Axogen Inc (AXGN) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Enveric Biosciences Inc — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Enveric Biosciences Inc trades at $1.25 (market cap $5.32M). The key difference: Axogen Inc is far larger — about 387.2× Enveric Biosciences Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | ENVB | |
|---|---|---|
Market Cap | $2.06B | $5.32M |
Sector | Technology | Health |
52-Week High | $46.19 | $17.40 |
52-Week Low | $11.28 | $1.28 |
Enterprise Value | $1.98B | $408.82K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
